| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/22/2002 | CA2438590A1 Therapeutic methods and agents for diseases associated with decreased expression of aop-1 gene or aop-1 |
| 08/22/2002 | CA2438551A1 Ppar agonists |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438492A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2438113A1 2-alkoxyphenyl substituted imidazotriazinones |
| 08/22/2002 | CA2437643A1 Matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2437588A1 Triazolo compounds as mmp inhibitors |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | CA2437333A1 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 08/22/2002 | CA2437122A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | CA2436713A1 Proteins and nucleic acids encoding same |
| 08/22/2002 | CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2436195A1 Laulimalide derivatives |
| 08/22/2002 | CA2436176A1 Thrombin inhibitors |
| 08/22/2002 | CA2436068A1 Thrombin inhibitors |
| 08/22/2002 | CA2435376A1 Isophthalic acid derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2434982A1 Pyridine matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2434835A1 Novel modified released formulation |
| 08/22/2002 | CA2434833A1 Pharmaceutical composition for treating chronic heart failure |
| 08/22/2002 | CA2434542A1 Novel modified release formulation |
| 08/22/2002 | CA2433936A1 Localized myocardial injection method for treating ischemic myocardium |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2433778A1 Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2433075A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/22/2002 | CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | CA2426535A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 08/21/2002 | EP1233018A2 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233017A1 Tricyclic sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233016A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1233015A1 Use of imidazole derivatives for the treatement of deseases involving the AT1 and AT2s receptors of angiotensine, some of these products, their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 08/21/2002 | EP1233013A1 Novel phenylalanine derivatives |
| 08/21/2002 | EP1232750A1 Non-beta-oxidizable fatty acid analogues and their use for reduction of growth of cancer cells |
| 08/21/2002 | EP1232749A1 Non-beta-oxidizable fatty acid analogues and their uses for inhibition of oxidative modification of low density lipoprotein |
| 08/21/2002 | EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 08/21/2002 | EP1232266A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232254A1 Process for the production of a reversibly inactive acidified plasmin composition |
| 08/21/2002 | EP1232252A1 Reversibly inactivated acidified plasmin |
| 08/21/2002 | EP1232251A1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
| 08/21/2002 | EP1232247A2 Modulation of signal transduction |
| 08/21/2002 | EP1232183A2 Peptides having antiangiogenic activity |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/21/2002 | EP1232172A1 Novel ribose compounds |
| 08/21/2002 | EP1232156A1 Novel 1,2,3]-triazolo 4,5-d]pyrimidine compounds |
| 08/21/2002 | EP1232153A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1232144A2 Novel il-8 receptor antagonists |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1231944A2 Targeted delivery of therapeutic and diagnostic moieties |
| 08/21/2002 | EP1231916A2 Use of indirubine derivatives for making medicines |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP1231907A2 Dextrose and insulin fluid formulation for intravenous infusion |
| 08/21/2002 | EP1154801A4 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 08/21/2002 | EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 08/21/2002 | EP1041991A4 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 08/21/2002 | EP0980251B1 Tissue factor for influencing blood vessel formation |
| 08/21/2002 | EP0696194B1 Use of indole derivatives as 5ht1 antagonists |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1365395A Tenascin-C nucleic acid liqands |
| 08/21/2002 | CN1365363A thineopyranecarboxyamide derivatives |
| 08/21/2002 | CN1365360A Puring derivatives inhibitors of tyrosine kinase SYK |
| 08/21/2002 | CN1365356A Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 08/21/2002 | CN1365281A Metalloprotease inhibitors |
| 08/21/2002 | CN1365279A Preparations for reducing oxygen consumption during physical efforts |
| 08/21/2002 | CN1364617A Traditional Chinese medicine for curing cardio-cerebro vascular diseases |
| 08/21/2002 | CN1364615A Medicine for curing hemorrhoid, anal fissure and anal fistula |
| 08/21/2002 | CN1364614A Intravenous injection for curing cardiovascular system diseases and its preparing method |
| 08/21/2002 | CN1364592A Medicine for curing coronary heart disease |
| 08/21/2002 | CN1364586A Traditional Chinese medicine compound oral sticking film for coronary heart disease and angina pectoris |
| 08/21/2002 | CN1364570A Nano palpitation relieving and blood pressure lowering medicine and its preparing method |
| 08/21/2002 | CN1364566A Nano pile fast curing medicine and its preparing method |
| 08/21/2002 | CN1364548A Nano Kanghong medicine and its preparing method |
| 08/21/2002 | CN1364536A Nano eight ingredient eagle wood medicine and its preparing method |
| 08/21/2002 | CN1364526A Nano chest relaxing medicine and its preparing method |
| 08/21/2002 | CN1364520A Nano fengtong medicine and its preparing method |
| 08/21/2002 | CN1364516A Nano Breviscapine medicine and its preparing method |
| 08/21/2002 | CN1364509A Nano seventy ingredient pearl medicine and its preparing method |
| 08/21/2002 | CN1364479A Nano gastrodia tuber and fleece-flower root medicine and its preparing method |
| 08/21/2002 | CN1364466A Hemorrhoidal powder |
| 08/21/2002 | CN1364461A Medicinal use of hypotensive and anti-tumour compound |
| 08/21/2002 | CN1089238C Method for lowering cholesterol |
| 08/21/2002 | CN1089237C Compound for use in preparing medium for inhibiting vascular smooth muscle cell migration |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437143 Thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 08/20/2002 | US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them |
| 08/20/2002 | US6436997 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 08/20/2002 | US6436992 Use of fumaric acid derivatives |
| 08/20/2002 | US6436991 Composition and method containing products extracted from Commiphora sp. for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease |
| 08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
| 08/20/2002 | US6436977 Dosing regimens for lasofoxifene |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436960 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 08/20/2002 | US6436957 Indole derivatives as 5-HT1 agonists |
| 08/20/2002 | US6436952 Cyclic nucleotide phosphodiesterase inhibitors; inflammatory airway disorders, such as asthma; antiinflammatory; 6-(4-(2h-2-ethyltetrazol-5-yl) phenyl)-1,2,3,4,4a,10b-hexahydrobenzo(c)(1,6)naohthyridine n-2-oxides |
| 08/20/2002 | US6436949 Heterocyclically substituted benzamides and their use |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |